Russell Investments Group Ltd. Acquires 863 Shares of Integer Holdings Corporation $ITGR

Russell Investments Group Ltd. boosted its position in Integer Holdings Corporation (NYSE:ITGR) by 14.7% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,749 shares of the medical equipment provider’s stock after purchasing an additional 863 shares during the quarter. Russell Investments Group Ltd.’s holdings in Integer were worth $796,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also bought and sold shares of ITGR. Vaughan Nelson Investment Management L.P. purchased a new stake in Integer in the 1st quarter worth approximately $33,337,000. Nuveen LLC purchased a new stake in Integer in the 1st quarter worth approximately $17,634,000. GAMMA Investing LLC lifted its stake in Integer by 8,697.6% in the 1st quarter. GAMMA Investing LLC now owns 78,123 shares of the medical equipment provider’s stock worth $92,190,000 after purchasing an additional 77,235 shares in the last quarter. Universal Beteiligungs und Servicegesellschaft mbH purchased a new stake in Integer in the 4th quarter worth approximately $7,889,000. Finally, Northern Trust Corp lifted its stake in Integer by 14.2% in the 4th quarter. Northern Trust Corp now owns 422,380 shares of the medical equipment provider’s stock worth $55,974,000 after purchasing an additional 52,556 shares in the last quarter. 99.29% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research firms have issued reports on ITGR. Wall Street Zen upgraded shares of Integer from a “hold” rating to a “buy” rating in a research note on Saturday. Raymond James Financial lowered their price objective on shares of Integer from $150.00 to $143.00 and set an “outperform” rating on the stock in a research report on Friday, July 25th. Wells Fargo & Company lowered their price objective on shares of Integer from $152.00 to $132.00 and set an “overweight” rating on the stock in a research report on Friday, July 25th. Truist Financial lowered their price objective on shares of Integer from $145.00 to $137.00 and set a “buy” rating on the stock in a research report on Friday, July 25th. Finally, Citigroup upgraded shares of Integer from a “hold” rating to a “strong-buy” rating and raised their price objective for the company from $133.00 to $140.00 in a research report on Thursday, May 22nd. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat, Integer has a consensus rating of “Buy” and an average target price of $140.25.

Insider Buying and Selling at Integer

In other Integer news, Director Donald J. Spence sold 14,739 shares of the firm’s stock in a transaction on Wednesday, June 4th. The shares were sold at an average price of $120.38, for a total value of $1,774,280.82. Following the sale, the director owned 18,781 shares of the company’s stock, valued at $2,260,856.78. This trade represents a 43.97% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Martin C. Maxwell sold 8,720 shares of the firm’s stock in a transaction on Thursday, June 5th. The stock was sold at an average price of $120.56, for a total transaction of $1,051,283.20. Following the completion of the sale, the director directly owned 22,170 shares in the company, valued at approximately $2,672,815.20. This trade represents a 28.23% decrease in their position. The disclosure for this sale can be found here. 2.16% of the stock is currently owned by company insiders.

Integer Price Performance

ITGR stock opened at $107.58 on Friday. The company has a debt-to-equity ratio of 0.72, a quick ratio of 2.18 and a current ratio of 3.41. Integer Holdings Corporation has a 52 week low of $104.93 and a 52 week high of $146.36. The firm’s fifty day moving average is $112.71 and its 200 day moving average is $118.09. The firm has a market cap of $3.77 billion, a P/E ratio of 47.39, a P/E/G ratio of 0.85 and a beta of 1.02.

Integer (NYSE:ITGR) last released its earnings results on Thursday, July 24th. The medical equipment provider reported $1.55 EPS for the quarter, missing the consensus estimate of $1.57 by ($0.02). Integer had a net margin of 4.61% and a return on equity of 12.27%. The business had revenue of $476.00 million for the quarter, compared to the consensus estimate of $464.37 million. During the same period in the prior year, the business posted $1.30 EPS. Integer’s revenue for the quarter was up 11.4% on a year-over-year basis. Integer has set its FY 2025 guidance at 6.250-6.510 EPS. Research analysts predict that Integer Holdings Corporation will post 6.01 earnings per share for the current year.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.